CMC Regulatory Services, LLC is a specialized CMC and Regulatory Affairs consultancy dedicated to helping biopharmaceutical companies transform complex science into successful regulatory submissions.

For more than three decades, we have supported sponsors across all stages of development—from early IND-enabling programs through NDA and BLA approvals. Our core focus is Chemistry, Manufacturing, and Controls (CMC), with deep expertise in authoring, editing, and strategically structuring FDA-ready Module 3 submissions.

We provide both hands-on technical execution and high-level regulatory strategy. Whether a company needs targeted authorship of specific sections, complete Module 3 development, lifecycle management support, or strategic guidance in response to FDA feedback, we deliver practical, risk-based solutions grounded in regulatory science.

Our experience spans small emerging biotechs to established global pharmaceutical companies. We have worked across diverse therapeutic modalities, including complex biologics, therapeutic proteins, cell and gene therapies, and combination products. In addition to de novo submission development, we frequently assist clients in resolving CMC deficiencies, addressing Complete Response Letters, and rescuing challenged regulatory programs.

We are known for precision, clarity, and disciplined document architecture. Our approach emphasizes proactive communication with Health Authorities, alignment with current FDA expectations, and meticulous attention to detail to prevent costly delays.

At our core, we help companies overcome regulatory CMC challenges through thoughtful strategy, technical rigor, and innovative problem-solving.

CMC Regulatory Services, LLC

Org chart

Teams

Offices